NGM Biopharmaceuticals Ownership 2024 | Who Owns NGM Biopharmaceuticals Now?
Institutional Ownership
41.82%
Insider Ownership
21.08%
Retail Ownership
37.10%
Institutional Holders
74.00
NGM Biopharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -21,480 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,500 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,721 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -15,407 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -372,733 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,869 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -823,111 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,324,392 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,260 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -35,061 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -154,456 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,029 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,252 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -46,000 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -284,649 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -209,298 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -155,462 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -12,936 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,373 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -25,147 | -100.00% | - | Jun 30, 2024 |
NGM Biopharmaceuticals's largest institutional shareholder is AMERICAN INTERNATIONAL GROUP, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -21,480 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,500 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,721 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -15,407 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -372,733 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,869 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -823,111 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,324,392 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,260 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -35,061 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -154,456 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,029 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,252 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -46,000 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -284,649 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -209,298 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -155,462 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -12,936 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,373 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -25,147 | -100.00% | - | Jun 30, 2024 |
The largest NGM Biopharmaceuticals shareholder by % of total assets is AMERICAN INTERNATIONAL GROUP, INC.. The company owns 0.00 shares of NGM Biopharmaceuticals (NGM), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -75 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -96 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -346 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -777 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,052 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,095 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,373 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,029 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,117 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -3,654 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -4,381 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,252 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,869 | -100.00% | - | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | - | - | - | -11,644 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -12,936 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,074 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -15,407 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -15,654 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -15,910 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, NGM Biopharmaceuticals's largest institutional buyer is NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC. The company purchased -7.00 stocks of NGM, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | - | - | - | -18,136,735 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -3,004,210 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,324,392 | -100.00% | - | Jun 30, 2024 |
| STEPSTONE GROUP LP | - | - | - | -1,573,357 | -100.00% | - | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | - | - | - | -992,168 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -983,836 | -100.00% | - | Jun 30, 2024 |
| TRIUM CAPITAL LLP | - | - | - | -977,965 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -823,111 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -816,581 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -611,300 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -372,733 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -360,599 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -284,649 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -209,298 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -186,232 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -181,366 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -171,397 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -155,462 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -154,456 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -133,225 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, NGM Biopharmaceuticals's biggest institutional seller is COLUMN GROUP LLC. The company sold -18.14M shares of NGM, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLUMN GROUP LLC | - | - | - | -18,136,735 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -3,004,210 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,324,392 | -100.00% | - | Jun 30, 2024 |
| STEPSTONE GROUP LP | - | - | - | -1,573,357 | -100.00% | - | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | - | - | - | -992,168 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -983,836 | -100.00% | - | Jun 30, 2024 |
| TRIUM CAPITAL LLP | - | - | - | -977,965 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -823,111 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -816,581 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -611,300 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -372,733 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -360,599 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -284,649 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -209,298 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -186,232 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -181,366 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -171,397 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -155,462 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -154,456 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -133,225 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -98,037 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -94,178 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -70,636 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -66,344 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -66,180 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -64,310 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -48,708 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -46,000 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -45,436 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -35,061 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -33,529 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,260 | -100.00% | - | Jun 30, 2024 |
| DIKER MANAGEMENT LLC | - | - | - | -29,996 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -27,800 | -100.00% | - | Jun 30, 2024 |
| CLARIUS GROUP, LLC | - | - | - | -26,912 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -26,022 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -25,721 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -25,147 | -100.00% | - | Jun 30, 2024 |
| CARSON ADVISORY INC. | - | - | - | -22,550 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -22,269 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -21,480 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -21,169 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -19,796 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -19,458 | -100.00% | - | Jun 30, 2024 |
| JASPER RIDGE PARTNERS, L.P. | - | - | - | -19,250 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -18,500 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -16,963 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -15,910 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -15,654 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -15,407 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -15,074 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -12,936 | -100.00% | - | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | - | - | - | -11,644 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -10,869 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -10,252 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -4,381 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -3,654 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,117 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,029 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,373 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,095 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,052 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -777 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -346 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -96 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -75 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7 | -100.00% | - | Jun 30, 2024 |
NGM Biopharmaceuticals's largest sold out institutional shareholder by shares sold is COLUMN GROUP LLC, sold -18.14M shares, valued at -, as of undefined.
NGM Biopharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Advantage SMID Cap Fund, Inc. | 0.18% | 34,488 | - | - | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.14% | 337,511 | -196,166 | -36.76% | Jan 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.14% | 130,826 | - | - | Feb 29, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.09% | 6,831 | - | - | Sep 30, 2022 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 44,858 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.08% | 195,000 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.08% | 690,000 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.04% | 955 | - | - | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.03% | 604,602 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.02% | 12,751 | 1,780 | 16.22% | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 18,916 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,149 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 70,260 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 33,319 | - | - | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 946,116 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.01% | 19,262 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 47,599 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 22,618 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.01% | 125,917 | 20,181 | 19.09% | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 292,300 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,868,340 | -521,537 | -21.82% | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 54,435 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 28,902 | - | - | Aug 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 198,498 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 761 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 99,615 | - | - | Jan 31, 2024 |
| ETF Managers Trust | 0.00% | 15,271 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 28,899 | -3 | -0.01% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 85,514 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 316,961 | -43,621 | -12.10% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 18,045 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,923 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 255,800 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 15,170 | 775 | 5.38% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 28,291 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,117 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 22,437 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,422 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 12,074 | -526 | -4.17% | Mar 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 153,478 | 784 | 0.51% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 19,603 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 9,360 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 37,444 | - | - | Jan 31, 2024 |
| Ultimus Managers Trust | 0.00% | 4,383 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 197 | - | - | Apr 30, 2021 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 1,600 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 184,783 | 6,786 | 3.81% | Feb 29, 2024 |
| JPMorgan Trust I | 0.00% | 351,949 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,322 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 16,560 | 6,800 | 69.67% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 653 | -7,150 | -91.63% | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,901 | - | - | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,008 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 20,573 | - | - | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 188,113 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 949 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 803 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,153 | - | - | Dec 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 48,976 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 11,888 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,953 | 783 | 36.08% | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 380,362 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 145,969 | -493 | -0.34% | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 502 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 14,406 | -5,627 | -28.09% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 1,642,988 | -99,966 | -5.74% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 397 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 189,259 | 19,597 | 11.55% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 8,562 | - | - | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 978 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 8,200 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 1,990 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 19,063 | -2,172 | -10.23% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 18,911 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 16,726 | -67 | -0.40% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 6,878 | -96,276 | -93.33% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 197 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,851 | -63 | -1.28% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 15,383 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 40,970 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 187 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 13,815 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 4,570 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 338 | -28 | -7.65% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,809 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 3,110 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,385 | -4,506 | -41.37% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 26 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,909 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,878 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 1,440 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 14,828 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 40,798 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 882 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 15,432 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 477 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 15,360 | -219,059 | -93.45% | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 918 | - | - | Feb 29, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 429 | - | - | Mar 31, 2024 |
NGM Biopharmaceuticals's largest mutual fund holder by % of total assets is "BlackRock Advantage SMID Cap Fund, Inc.", owning 34.49K shares, compromising 0.18% of its total assets.
NGM Biopharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 74 | -10.84% |
| 31 Dec, 23 | 83 | -10.75% |
| 30 Sep, 23 | 93 | -10.58% |
| 30 Jun, 23 | 104 | -16.13% |
| 31 Mar, 23 | 124 | -0.80% |
| 31 Dec, 22 | 125 | -6.02% |
| 30 Sep, 22 | 133 | 8.13% |
| 30 Jun, 22 | 123 | 8.85% |
| 31 Mar, 22 | 113 | -6.61% |
| 31 Dec, 21 | 121 | -6.20% |
| 30 Sep, 21 | 129 | 20.56% |
| 30 Jun, 21 | 107 | -1.83% |
| 31 Mar, 21 | 109 | 21.11% |
| 31 Dec, 20 | 90 | 9.76% |
| 30 Sep, 20 | 82 | -2.38% |
| 30 Jun, 20 | 84 | 15.07% |
| 31 Mar, 20 | 73 | 23.73% |
| 31 Dec, 19 | 59 | 20.41% |
| 30 Sep, 19 | 49 | 4.26% |
| 30 Jun, 19 | 47 | - |
As of 31 Mar 24, 74 institutions are holding NGM Biopharmaceuticals's shares, representing a decrease of -10.84% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 34,628,446 | -15.79% |
| 31 Dec, 23 | 41,123,369 | -12.96% |
| 30 Sep, 23 | 47,244,554 | -1.52% |
| 30 Jun, 23 | 47,971,646 | -1.55% |
| 31 Mar, 23 | 48,728,228 | -1.63% |
| 31 Dec, 22 | 49,536,264 | -6.09% |
| 30 Sep, 22 | 52,750,524 | 11.36% |
| 30 Jun, 22 | 47,370,697 | -1.43% |
| 31 Mar, 22 | 48,055,704 | 2.10% |
| 31 Dec, 21 | 47,065,073 | 4.04% |
| 30 Sep, 21 | 45,238,573 | 5.00% |
| 30 Jun, 21 | 43,085,754 | 0.12% |
| 31 Mar, 21 | 43,033,258 | 15.97% |
| 31 Dec, 20 | 37,106,168 | 8.49% |
| 30 Sep, 20 | 34,203,750 | 1.29% |
| 30 Jun, 20 | 33,767,965 | 3.84% |
| 31 Mar, 20 | 32,518,527 | 12.72% |
| 31 Dec, 19 | 28,848,836 | 9.43% |
| 30 Sep, 19 | 26,361,670 | 0.77% |
| 30 Jun, 19 | 26,159,475 | - |
NGM Biopharmaceuticals (NGM) has 34.63M shares outstanding as of 31 Mar 24, down -15.79% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 41.82% | 1.69% |
| 31 Dec, 23 | 49.72% | 1.51% |
| 30 Sep, 23 | 57.30% | 1.67% |
| 30 Jun, 23 | 58.50% | 1.66% |
| 31 Mar, 23 | 59.42% | 1.55% |
| 31 Dec, 22 | 61.96% | 1.45% |
| 30 Sep, 22 | 65.43% | 1.83% |
| 30 Jun, 22 | 59.76% | 1.58% |
| 31 Mar, 22 | 61.59% | 1.65% |
| 31 Dec, 21 | 61.06% | 1.79% |
| 30 Sep, 21 | 58.44% | 1.87% |
| 30 Jun, 21 | 55.89% | 1.74% |
| 31 Mar, 21 | 56.60% | 1.93% |
| 31 Dec, 20 | 54.19% | 2.19% |
| 30 Sep, 20 | 49.70% | 2.03% |
| 30 Jun, 20 | 49.44% | 2.12% |
| 31 Mar, 20 | 48.25% | 1.47% |
| 31 Dec, 19 | 57.36% | 3.59% |
| 30 Sep, 19 | 39.97% | 2.18% |
| 30 Jun, 19 | 42.85% | - |
As of 31 Mar 24, NGM Biopharmaceuticals is held by 41.82% institutional shareholders, representing a 1.69% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 30 | -11.76% |
| 31 Dec, 23 | 34 | -20.93% |
| 30 Sep, 23 | 43 | -14.00% |
| 30 Jun, 23 | 50 | -12.28% |
| 31 Mar, 23 | 57 | -31.33% |
| 31 Dec, 22 | 83 | 9.21% |
| 30 Sep, 22 | 76 | 1.33% |
| 30 Jun, 22 | 75 | 44.23% |
| 31 Mar, 22 | 52 | -16.13% |
| 31 Dec, 21 | 62 | -13.89% |
| 30 Sep, 21 | 72 | 14.29% |
| 30 Jun, 21 | 63 | -7.35% |
| 31 Mar, 21 | 68 | 47.83% |
| 31 Dec, 20 | 46 | 35.29% |
| 30 Sep, 20 | 34 | -34.62% |
| 30 Jun, 20 | 52 | 23.81% |
| 31 Mar, 20 | 42 | -8.70% |
| 31 Dec, 19 | 46 | 48.39% |
| 30 Sep, 19 | 31 | -34.04% |
| 30 Jun, 19 | 47 | - |
30 institutional shareholders have increased their position in NGM stock as of 31 Mar 24 compared to 34 in the previous quarter (a -11.76% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 27 | -20.59% |
| 31 Dec, 23 | 34 | - |
| 30 Sep, 23 | 34 | -8.11% |
| 30 Jun, 23 | 37 | -15.91% |
| 31 Mar, 23 | 44 | 91.30% |
| 31 Dec, 22 | 23 | -17.86% |
| 30 Sep, 22 | 28 | 3.70% |
| 30 Jun, 22 | 27 | -32.50% |
| 31 Mar, 22 | 40 | 21.21% |
| 31 Dec, 21 | 33 | 26.92% |
| 30 Sep, 21 | 26 | 23.81% |
| 30 Jun, 21 | 21 | 16.67% |
| 31 Mar, 21 | 18 | -40.00% |
| 31 Dec, 20 | 30 | -6.25% |
| 30 Sep, 20 | 32 | 77.78% |
| 30 Jun, 20 | 18 | 5.88% |
| 31 Mar, 20 | 17 | 142.86% |
| 31 Dec, 19 | 7 | -22.22% |
| 30 Sep, 19 | 9 | - |
| 30 Jun, 19 | - | - |
27 institutional shareholders have reduced their position in NGM stock as of 31 Mar 24 compared to 34 in the previous quarter (a -20.59% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 74 | -10.84% | 34,628,446 | -15.79% | 41.82% | 1.69% | 30 | -11.76% | 27 | -20.59% |
| 31 Dec, 23 | 83 | -10.75% | 41,123,369 | -12.96% | 49.72% | 1.51% | 34 | -20.93% | 34 | - |
| 30 Sep, 23 | 93 | -10.58% | 47,244,554 | -1.52% | 57.30% | 1.67% | 43 | -14.00% | 34 | -8.11% |
| 30 Jun, 23 | 104 | -16.13% | 47,971,646 | -1.55% | 58.50% | 1.66% | 50 | -12.28% | 37 | -15.91% |
| 31 Mar, 23 | 124 | -0.80% | 48,728,228 | -1.63% | 59.42% | 1.55% | 57 | -31.33% | 44 | 91.30% |
| 31 Dec, 22 | 125 | -6.02% | 49,536,264 | -6.09% | 61.96% | 1.45% | 83 | 9.21% | 23 | -17.86% |
| 30 Sep, 22 | 133 | 8.13% | 52,750,524 | 11.36% | 65.43% | 1.83% | 76 | 1.33% | 28 | 3.70% |
| 30 Jun, 22 | 123 | 8.85% | 47,370,697 | -1.43% | 59.76% | 1.58% | 75 | 44.23% | 27 | -32.50% |
| 31 Mar, 22 | 113 | -6.61% | 48,055,704 | 2.10% | 61.59% | 1.65% | 52 | -16.13% | 40 | 21.21% |
| 31 Dec, 21 | 121 | -6.20% | 47,065,073 | 4.04% | 61.06% | 1.79% | 62 | -13.89% | 33 | 26.92% |
| 30 Sep, 21 | 129 | 20.56% | 45,238,573 | 5.00% | 58.44% | 1.87% | 72 | 14.29% | 26 | 23.81% |
| 30 Jun, 21 | 107 | -1.83% | 43,085,754 | 0.12% | 55.89% | 1.74% | 63 | -7.35% | 21 | 16.67% |
| 31 Mar, 21 | 109 | 21.11% | 43,033,258 | 15.97% | 56.60% | 1.93% | 68 | 47.83% | 18 | -40.00% |
| 31 Dec, 20 | 90 | 9.76% | 37,106,168 | 8.49% | 54.19% | 2.19% | 46 | 35.29% | 30 | -6.25% |
| 30 Sep, 20 | 82 | -2.38% | 34,203,750 | 1.29% | 49.70% | 2.03% | 34 | -34.62% | 32 | 77.78% |
| 30 Jun, 20 | 84 | 15.07% | 33,767,965 | 3.84% | 49.44% | 2.12% | 52 | 23.81% | 18 | 5.88% |
| 31 Mar, 20 | 73 | 23.73% | 32,518,527 | 12.72% | 48.25% | 1.47% | 42 | -8.70% | 17 | 142.86% |
| 31 Dec, 19 | 59 | 20.41% | 28,848,836 | 9.43% | 57.36% | 3.59% | 46 | 48.39% | 7 | -22.22% |
| 30 Sep, 19 | 49 | 4.26% | 26,361,670 | 0.77% | 39.97% | 2.18% | 31 | -34.04% | 9 | - |
| 30 Jun, 19 | 47 | - | 26,159,475 | - | 42.85% | - | 47 | - | - | - |
NGM Biopharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of NGM Biopharmaceuticals's stock was made by TCG Opportunity III GP, LLC on Apr 08 2024, selling 44,000 shares at - per share (valued at -).
NGM Biopharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 4 | - |
| Q4 2023 | 28 | 20 | 140.00% |
| Q3 2023 | - | 5 | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 47 | 2 | 2350.00% |
| Q4 2022 | 35 | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 35 | - | - |
| Q1 2022 | 18 | - | - |
| Q4 2021 | 5 | 13 | 38.46% |
| Q3 2021 | 1 | 12 | 8.33% |
| Q2 2021 | 7 | 4 | 175.00% |
| Q1 2021 | 7 | 7 | 100.00% |
| Q4 2020 | - | 5 | - |
| Q3 2020 | 33 | 8 | 412.50% |
| Q2 2020 | 29 | 4 | 725.00% |
| Q1 2020 | 65 | 11 | 590.91% |
| Q4 2019 | 58 | 9 | 644.44% |
| Q3 2019 | 57 | - | - |
| Q2 2019 | 66 | 59 | 111.86% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by NGM Biopharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q4 2023 | 10 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 32 | 1 | 3200.00% |
| Q4 2022 | 34 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 30 | - | - |
| Q1 2022 | 12 | - | - |
| Q4 2021 | - | 8 | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | 4 | - |
| Q4 2020 | - | 5 | - |
| Q3 2020 | 30 | 5 | 600.00% |
| Q2 2020 | 20 | 3 | 666.67% |
| Q1 2020 | 56 | 3 | 1866.67% |
| Q4 2019 | 52 | 3 | 1733.33% |
| Q3 2019 | 57 | - | - |
| Q2 2019 | 49 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of NGM Biopharmaceuticals's stocks.
NGM Biopharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| SANA | Sana Biotechnology, Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| PRLD | Prelude Therapeutics Incorporated |
| FHTX | Foghorn Therapeutics Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| GBIO | Generation Bio Co. |
| LYEL | Lyell Immunopharma, Inc. |
| KROS | Keros Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| NKTX | Nkarta, Inc. |
| NLTX | Neurogene Inc. |
| KZR | Kezar Life Sciences, Inc. |
| TIL | Instil Bio, Inc. |
NGM Ownership FAQ
Who Owns NGM Biopharmaceuticals?
NGM Biopharmaceuticals is owned by institutional shareholders (41.82%), insiders (21.08%), and public (37.10%). The largest institutional shareholder of NGM Biopharmaceuticals is AMERICAN INTERNATIONAL GROUP, INC. (0% of total shares) and the top mutual fund owner is BlackRock Advantage SMID Cap Fund, Inc. (0.18% of total shares).
Who are the major institutional shareholders of NGM Biopharmaceuticals?
NGM Biopharmaceuticals's major institutional shareholders are AMERICAN INTERNATIONAL GROUP, INC., JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0% of the company's share outstanding.
How many NGM Biopharmaceuticals shareholders are there?
As of Mar 2024, there are 74 institutional shareholders of NGM Biopharmaceuticals.
What percentage of NGM Biopharmaceuticals is owned by AMERICAN INTERNATIONAL GROUP, INC?
AMERICAN INTERNATIONAL GROUP, INC owns 0 shares of NGM Biopharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of NGM Biopharmaceuticals is owned by JPMORGAN CHASE & CO?
As of Jun 2024, JPMORGAN CHASE & CO holds 0 shares of NGM Biopharmaceuticals (NGM), compromising 0% of the company, valued at $0.
What percentage of NGM Biopharmaceuticals is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of NGM Biopharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).